Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.48
-0.10 (-1.71%)
Jul 21, 2026, 10:07 AM EDT - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $897.04 million as of July 21, 2026. Its market cap has increased by 252.42% in one year.
Market Cap
897.04M
Enterprise Value
713.01M
1-Year Change
252.42%
Ranking
Category
Stock Price
$5.48
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $897.04M, an increase of 40.27%. That is a compound annual growth rate of 5.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 897.04M | 19.88% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 978.80M |
| Avalo Therapeutics | 963.36M |
| Kura Oncology | 948.11M |
| Vor Biopharma | 945.54M |
| Sana Biotechnology | 941.68M |
| Geron | 923.79M |
| Pharming Group | 911.72M |
| LB Pharmaceuticals | 886.11M |